Cost–utility analysis of once-daily versus twice-daily inhaled corticosteroid dosing for maintenance treatment of asthma in pediatric patients

References

• Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980–2007. Pediatrics 2009;123(Suppl 3):S131–S145
   PubMed Web of Science ®Google Scholar
• Dennis RJ, Caraballo L, García E, Rojas MX, Rondon MA, Pérez A, Aristizabal G, et al. Prevalence of asthma and other allergic conditions in Colombia 2009-2010: a cross-sectional study. BMC Pulm Med 2012;12:17
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Center for Health Statistics. CDC Wonder On-line Database, compiled from Compressed Mortality File 1999–2011 Series 20 No. 2Q, 2014
   Google Scholar
• Morton RW, Everard ML, Elphick HE. Adherence in childhood asthma: the elephant in the room. Arch Dis Child 2014;99:949–953
   PubMed Web of Science ®Google Scholar
• Horne R. Adherence to asthma medication: a question of ability? Prim Care Respir J 2011;20:118–119
   PubMedGoogle Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296–1310
   PubMed Web of Science ®Google Scholar
• Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881–1884
   PubMed Web of Science ®Google Scholar
• Boulet LP, Vervloet D, Magar Y, Foster JM. Adherence: the goal to control asthma. Clin Chest Med 2012;33:405–417
   PubMed Web of Science ®Google Scholar
• Masoli M, Weatherall M, Beasley R. Fluticasone given once versus twice a day: meta-analysis. Respirology 2005;10:183–188
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martinez CE, Sossa-Briceno MP, Castro-Rodriguez JA. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma. J Asthma 2013;50:410–418
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martinez CE, Nino G, Castro-Rodriguez JA. Cost-utility analysis of daily versus intermittent inhaled corticosteroids in mild-persistent asthma. Pediatr Pulmonol 2015;50:735–746
   PubMed Web of Science ®Google Scholar
• Adams N, Lasserson TJ, Cates CJ, Jones PW. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children. Cochrane Database Syst Rev 2007;4:Cd002310. DOI: 10.1002/14651858.CD002310.pub4
   PubMed Web of Science ®Google Scholar
• Manning P, Gibson PG, Lasserson TJ. Ciclesonide versus other inhaled steroids for chronic asthma in children and adults. Cochrane Database Syst Rev 2008;2:Cd007031. DOI: 10.1002/14651858.CD007031
   Google Scholar
• Kelly HW. Comparison of inhaled corticosteroids: an update. Ann Pharmacother. 2009;43:519–27
   PubMed Web of Science ®Google Scholar
• Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397–409
   PubMed Web of Science ®Google Scholar
• Price MJ, Briggs AH. Development of an economic model to assess the cost effectiveness of asthma management strategies. Pharmacoeconomics 2002;20:183–194
   PubMed Web of Science ®Google Scholar
• Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol 2011;127:145–152
   PubMed Web of Science ®Google Scholar
• Martinez-Moragón E, Serra-Batllés J, De Diego A, Palop M, Casan P, Rubio-Terrés C, Pellicer C. por el Grupo de Investigadores del estudio AsmaCost. Arch Bronconeumol 2009;45:481–486
   PubMed Web of Science ®Google Scholar
• Dubus JC, Anhoj J. A review of once-daily delivery of anti-asthmatic drugs in children. Pediatr Allergy Immunol 2003;14:4–9
   PubMed Web of Science ®Google Scholar
• Jonasson G, Carlsen KH, Jonasson C, Mowinckel P. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma. Allergy 2000;55:740–748
   PubMed Web of Science ®Google Scholar
• Wells KE, Peterson EL, Ahmedani BK, Williams LK. Real-world effects of once vs greater daily inhaled corticosteroid dosing on medication adherence. Ann Allergy Asthma Immunol 2013;111:216–220
   PubMed Web of Science ®Google Scholar
• Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994;149:S69–S76
   PubMed Web of Science ®Google Scholar
• Celano MP, Linzer JF, Demi A, Bakeman R, Smith CO, Croft S, Kobrynski LJ. Treatment adherence among low-income, African American children with persistent asthma. J Asthma 2010;47:317–322
   PubMed Web of Science ®Google Scholar
• Jentzsch NS, Camargos P, Sarinho ES, Bousquet J. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med 2012;106:338–343
   PubMed Web of Science ®Google Scholar
• Jentzsch NS, Camargos PA, Colosimo EA, Bousquet J. Monitoring adherence to beclomethasone in asthmatic children and adolescents through four different methods. Allergy 2009;64:1458–1462
   PubMed Web of Science ®Google Scholar
• McNally KA, Rohan J, Schluchter M, Riekert KA, Vavrek P, Schmidt A, Redline S, et al. Adherence to combined montelukast and fluticasone treatment in economically disadvantaged african american youth with asthma. J Asthma 2009;46:921–927
   PubMed Web of Science ®Google Scholar
• Mallol J, Aguirre V. Once versus twice daily budesonide metered-dose inhaler in children with mild to moderate asthma: effect on symptoms and bronchial responsiveness. Allergolog Immunopathol 2007;35:25–31
   PubMed Web of Science ®Google Scholar
• Briggs A, Claxton K, Sculpher M. Decision modeling for health economic evaluation. New York: Oxford University Press; 2006
   Google Scholar
• Shih YC, Mauskopf J, Borker R. A cost-effectiveness analysis of first-line controller therapies for persistent asthma. Pharmacoeconomics 2007;25:577–590
   PubMed Web of Science ®Google Scholar
• Chiou CF, Weaver MR, Bell MA, Lee TA, Krieger JW. Development of the multi-attribute Pediatric Asthma Health Outcome Measure (PAHOM). Int J Qual Health Care 2005;17:23–30
   PubMed Web of Science ®Google Scholar
• Sistema de Información de precios de medicamentos—SISMED. Listado de precios promedio y unidades en la cadena de comercialización de medicamentos. Ministerio de la Protección Social. República de Colombia. Available from: http://www.consultorsalud.com/biblioteca/documentos/2012/Precios%20reportados%20de%20medicamentos%20diciembre%202011.pdf [last accessed 15 April 2015]
   Google Scholar
• Guıa de Práctica Clínica (GPC) para el diagnóstico, atención integral y seguimiento de niños y niñas con diagnóstico de asma. Available from: http://gpc.minsalud.gov.co/guias/Pages/Guía-de-asma-en-niños.aspx [last accessed 18 April 2015]
   Google Scholar
• British Guideline on the Management of Asthma. A national clinical guideline. British Thoracic Society. Scottish Intercollegiate Guidelines Network. Revised edition published 2014. Available from: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2014/ [last accessed 18 April 2015]
   Google Scholar
• Linstone H, Turoff M. The Delphi method. Techniques and applications. Los Angeles, CA: University of Southern California; 2002
   Google Scholar
• Banco de la República, Colombia. Series estadísticas. Tasas de cambio. Santa Fe de Bogota: Banco de la República; 2011. Available from: http://www.banrep.gov.co/series-estadisticas/see_ts_cam.htm [last accessed 19 April 2015]
   Google Scholar
• O'Brien BJ, Drummond MF, Labelle RJ, Willan A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994;32:150–163
   PubMed Web of Science ®Google Scholar
• Briggs AH, Goeree R, Blackhouse G, O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 2002;22:290–308
   PubMed Web of Science ®Google Scholar
• Miller-Larsson A, Mattsson H, Hjertberg E, Dahlback M, Tunek A, Brattsand R. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue. Drug Metab Dispos 1998;26:623–630
   PubMed Web of Science ®Google Scholar
• Boulet LP. Once-daily inhaled corticosteroids for the treatment of asthma. Curr Opin Pulm Med 2004;10:15–21
   PubMed Web of Science ®Google Scholar
• Kelly HW. Comparison of inhaled corticosteroids: an update. Ann Pharmacother 2009;43:519–527
   PubMed Web of Science ®Google Scholar
• Weiner P, Weiner M, Azgad Y. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Thorax 1995;50:1270–1273
   PubMed Web of Science ®Google Scholar
• Bush A, Zar HJ. WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol 2011;11:115–121
   PubMed Web of Science ®Google Scholar
• Guest JF, Davie AM, Ruiz FJ, Greener MJ. Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costs. Prim Care Respir J 2005;14:88–98
   PubMedGoogle Scholar
• Richter A, Anton SE, Koch P, Dennett SL. The impact of reducing dose frequency on health outcomes. Clin Ther 2003;25:2307–2335
   PubMed Web of Science ®Google Scholar
• Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol 2004;4:191–195
   PubMed Web of Science ®Google Scholar